{"transactions":[{"id":729217,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-06-23T21:21:19.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027."}],"balance_after":14950,"derivative":{"exercise_price":34.16,"expiration_date":"2036-06-18","underlying":"Common stock","underlying_shares":14950},"source":{"system":"sec-edgar","filing":"0001439222-26-000097","document":"wk-form4_1782249676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000097/wk-form4_1782249676.xml","form_type":"4"}},{"id":729216,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:21:19.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2927,"derivative":{"underlying":"Common stock","underlying_shares":2927},"source":{"system":"sec-edgar","filing":"0001439222-26-000097","document":"wk-form4_1782249676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000097/wk-form4_1782249676.xml","form_type":"4"}},{"id":729215,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:21:19.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-26-000097","document":"wk-form4_1782249676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000097/wk-form4_1782249676.xml","form_type":"4"}},{"id":729214,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-23T21:21:19.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10865,"source":{"system":"sec-edgar","filing":"0001439222-26-000097","document":"wk-form4_1782249676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000097/wk-form4_1782249676.xml","form_type":"4"}},{"id":736333,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-16T20:09:44.000Z","date":"2026-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001439222-26-000077","document":"wk-form4_1781640580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000077/wk-form4_1781640580.xml","form_type":"4"}},{"id":736332,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-16T20:09:44.000Z","date":"2026-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8049,"source":{"system":"sec-edgar","filing":"0001439222-26-000077","document":"wk-form4_1781640580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922226000077/wk-form4_1781640580.xml","form_type":"4"}},{"id":827637,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:15.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":23509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":70530,"derivative":{"underlying":"Common Stock","underlying_shares":23509},"source":{"system":"sec-edgar","filing":"0001816838-26-000003","document":"form4-03262026_080310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181683826000003/form4-03262026_080310.xml","form_type":"4"}},{"id":827636,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:15.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":11641,"price":21.47,"value":249932.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":14803,"source":{"system":"sec-edgar","filing":"0001816838-26-000003","document":"form4-03262026_080310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181683826000003/form4-03262026_080310.xml","form_type":"4"}},{"id":827635,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:15.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":23509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,935 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan."}],"balance_after":26444,"source":{"system":"sec-edgar","filing":"0001816838-26-000003","document":"form4-03262026_080310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181683826000003/form4-03262026_080310.xml","form_type":"4"}},{"id":851802,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T22:00:08.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":76509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."}],"balance_after":76509,"derivative":{"underlying":"Common Stock","underlying_shares":76509},"source":{"system":"sec-edgar","filing":"0001816838-26-000002","document":"form4-03102026_060303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181683826000002/form4-03102026_060303.xml","form_type":"4"}},{"id":851801,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-10T22:00:08.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":263005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":263005,"derivative":{"exercise_price":22.16,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":263005},"source":{"system":"sec-edgar","filing":"0001816838-26-000002","document":"form4-03102026_060303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000181683826000002/form4-03102026_060303.xml","form_type":"4"}},{"id":1103893,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:20:15.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-25-000051","document":"wk-form4_1750710009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000051/wk-form4_1750710009.xml","form_type":"4"}},{"id":1103892,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-23T20:20:15.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026."}],"balance_after":15768,"derivative":{"exercise_price":35.5,"expiration_date":"2035-06-18","underlying":"Common stock","underlying_shares":15768},"source":{"system":"sec-edgar","filing":"0001439222-25-000051","document":"wk-form4_1750710009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000051/wk-form4_1750710009.xml","form_type":"4"}},{"id":1103891,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:20:15.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2816,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-25-000051","document":"wk-form4_1750710009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000051/wk-form4_1750710009.xml","form_type":"4"}},{"id":1103890,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-23T20:20:15.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6073,"source":{"system":"sec-edgar","filing":"0001439222-25-000051","document":"wk-form4_1750710009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000051/wk-form4_1750710009.xml","form_type":"4"}},{"id":1108099,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-17T20:15:10.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1976,"derivative":{"underlying":"Common stock","underlying_shares":1977},"source":{"system":"sec-edgar","filing":"0001439222-25-000043","document":"wk-form4_1750191300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000043/wk-form4_1750191300.xml","form_type":"4"}},{"id":1108098,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-17T20:15:10.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1977,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3953,"source":{"system":"sec-edgar","filing":"0001439222-25-000043","document":"wk-form4_1750191300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922225000043/wk-form4_1750191300.xml","form_type":"4"}},{"id":1191448,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-26T23:49:52.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":94039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":94039,"derivative":{"underlying":"Common Stock","underlying_shares":94039},"source":{"system":"sec-edgar","filing":"0001415889-25-009067","document":"form4-03262025_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009067/form4-03262025_110347.xml","form_type":"4"}},{"id":1191447,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Adams Catherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-26T23:49:52.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":319976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":319976,"derivative":{"exercise_price":17.23,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":319976},"source":{"system":"sec-edgar","filing":"0001415889-25-009067","document":"form4-03262025_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009067/form4-03262025_110347.xml","form_type":"4"}},{"id":1399652,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Adams Catherine Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-25T22:53:04.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":353261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Stock Option has been granted pursuant to the Issuer's 2024 Inducement Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Stock Option will vest and become exercisable on September 23, 2025.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":353261,"derivative":{"exercise_price":16.29,"expiration_date":"2034-09-22","underlying":"Common Stock","underlying_shares":353261},"source":{"system":"sec-edgar","filing":"0001415889-24-023975","document":"form4-09252024_100900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924023975/form4-09252024_100900.xml","form_type":"4"}},{"id":1470760,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-06-24T20:09:50.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":11774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025."}],"balance_after":11774,"derivative":{"exercise_price":42.45,"expiration_date":"2034-06-20","underlying":"Common stock","underlying_shares":11774},"source":{"system":"sec-edgar","filing":"0001439222-24-000103","document":"wk-form4_1719259783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922224000103/wk-form4_1719259783.xml","form_type":"4"}},{"id":1470759,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-24T20:09:50.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2120,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-24-000103","document":"wk-form4_1719259783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922224000103/wk-form4_1719259783.xml","form_type":"4"}},{"id":1477435,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-17T21:15:52.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":3953,"derivative":{"underlying":"Common stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001439222-24-000077","document":"wk-form4_1718658945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922224000077/wk-form4_1718658945.xml","form_type":"4"}},{"id":1477434,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-06-17T21:15:52.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1976,"source":{"system":"sec-edgar","filing":"0001439222-24-000077","document":"wk-form4_1718658945.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922224000077/wk-form4_1718658945.xml","form_type":"4"}},{"id":1487026,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:20:12.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 6, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":1.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001494650-24-000079","document":"wk-form4_1717791604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465024000079/wk-form4_1717791604.xml","form_type":"4"}},{"id":1854569,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2023-06-15T20:32:15.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":33177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 13, 2023. The shares underlying this option vest as to 25% of the underlying shares on June 13, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":33177,"derivative":{"exercise_price":26.56,"expiration_date":"2033-06-13","underlying":"Common stock","underlying_shares":33177},"source":{"system":"sec-edgar","filing":"0001439222-23-000089","document":"wk-form4_1686861126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922223000089/wk-form4_1686861126.xml","form_type":"4"}},{"id":1854568,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-06-15T20:32:15.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":5929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":5929,"derivative":{"underlying":"Common stock","underlying_shares":5929},"source":{"system":"sec-edgar","filing":"0001439222-23-000089","document":"wk-form4_1686861126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000143922223000089/wk-form4_1686861126.xml","form_type":"4"}},{"id":1860807,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:00:15.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":53500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 8, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":53500,"derivative":{"exercise_price":1.18,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":53500},"source":{"system":"sec-edgar","filing":"0001494650-23-000052","document":"wk-form4_1686333605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465023000052/wk-form4_1686333605.xml","form_type":"4"}},{"id":2237943,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T14:19:58.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 8, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":32000,"derivative":{"exercise_price":1.95,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001494650-22-000062","document":"wf-form4_165478438556796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465022000062/wf-form4_165478438556796.xml","form_type":"4"}},{"id":2674178,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T19:13:04.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":14439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 9, 2022 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2022 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":14439,"derivative":{"exercise_price":3.54,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":14439},"source":{"system":"sec-edgar","filing":"0001494650-21-000070","document":"wf-form4_162335236778720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465021000070/wf-form4_162335236778720.xml","form_type":"4"}},{"id":3073441,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T23:56:57.000Z","date":"2020-07-29","kind":"grant","acquired":true,"shares":28879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a three-year period commencing on July 29, 2020. Thirty-three percent (33%) of the option vests and becomes exercisable on July 29, 2021, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer."}],"balance_after":28879,"derivative":{"exercise_price":5.23,"expiration_date":"2030-07-29","underlying":"Common Stock","underlying_shares":28879},"source":{"system":"sec-edgar","filing":"0001494650-20-000088","document":"wf-form4_159615020877016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465020000088/wf-form4_159615020877016.xml","form_type":"4"}},{"id":3073440,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":36004,"kind":"person","name":"Owen Adams Catherine","position":1,"cik":"0001816838","reported_name":"Owen Catherine E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T23:55:48.000Z","date":"2020-07-29","kind":"grant","acquired":true,"shares":28879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a three-year period commencing on July 29, 2020. Thirty-three percent (33%) of the option vests and becomes exercisable on July 29, 2021, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer."}],"balance_after":28879,"derivative":{"exercise_price":5.23,"expiration_date":"2030-07-29","underlying":"Common Stock","underlying_shares":28879},"source":{"system":"sec-edgar","filing":"0001494650-20-000087","document":"wf-form4_159615002295860.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816838/000149465020000087/wf-form4_159615002295860.xml","form_type":"4"}}]}